Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
暂无分享,去创建一个
P. Chaturvedi | A. Mahajan | P. Pai | A. Bhattacharjee | S. Nair | S. Ghosh-Laskar | A. Budrukkar | M. Swain | K. Prabhash | V. Noronha | D. Chaukar | V. Patil | N. Purandare | A. Puranik | A. Balaji | S. Thiagarajan | N. Menon | V. Mathrudev | K. Nawale | Mitali Alone | R. Rai | Suman Kumar | Sayak Dey | A. Agarwal | Shantanu J. Pendse | R. Ravind | Kunal Jobanputra | Zoya Peelay | A. Singh | Shruti Pathak | Ajay Singh | Monica Reddy Yallala | Harsh Sahu | Venkatesh Kapu | Jatin Choudhary | Madala Ravi Krishna | Alok Shetty | Naveen Karuvandan | Z. Peelay | S. Nair